Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
Pushpa Narayanaswami, MD, FAAN
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Aravindhan Veerapandiyan, MD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Advancing Care: Clinical Innovations on the Horizon
John Vissing, MD, DMSci
Establishing Our Foundation of LGMD2I/R9
Conrad Weihl, MD, PhD
The Role of Multidisciplinary Care in LGMD2I/R9
Recognizing Early Signs of LGMD2I/R9
Integrating Perspectives: The Value of Patient and Caregiver Input
Epilepsy: Beyond Seizure Impact
Raman Sankar, MD, PhD
Scott Aaronson, MD
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Charles P. Vega, MD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.